- Home
- IGMS vs NA Comparison
IGMS vs NA Comparison
Compare IGMS & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGMS
- NA
- Stock Information
- Founded
- IGMS 1993
- NA 2019
- Country
- IGMS United States
- NA China
- Employees
- IGMS N/A
- NA N/A
- Industry
- IGMS Biotechnology: Pharmaceutical Preparations
- NA Semiconductors
- Sector
- IGMS Health Care
- NA Technology
- Exchange
- IGMS Nasdaq
- NA Nasdaq
- Market Cap
- IGMS 82.1M
- NA 77.6M
- IPO Year
- IGMS 2019
- NA 2022
- Fundamental
- Price
- IGMS $1.17
- NA $12.17
- Analyst Decision
- IGMS Hold
- NA
- Analyst Count
- IGMS 8
- NA 0
- Target Price
- IGMS $6.00
- NA N/A
- AVG Volume (30 Days)
- IGMS 211.8K
- NA 390.5K
- Earning Date
- IGMS 08-13-2025
- NA 03-25-2025
- Dividend Yield
- IGMS N/A
- NA N/A
- EPS Growth
- IGMS N/A
- NA N/A
- EPS
- IGMS N/A
- NA N/A
- Revenue
- IGMS $2,681,000.00
- NA $5,561,770.00
- Revenue This Year
- IGMS $134.30
- NA N/A
- Revenue Next Year
- IGMS $22.37
- NA N/A
- P/E Ratio
- IGMS N/A
- NA N/A
- Revenue Growth
- IGMS 27.36
- NA N/A
- 52 Week Low
- IGMS $0.92
- NA $2.75
- 52 Week High
- IGMS $22.50
- NA $13.86
- Technical
- Relative Strength Index (RSI)
- IGMS 42.70
- NA 76.74
- Support Level
- IGMS $1.17
- NA $7.75
- Resistance Level
- IGMS $1.40
- NA $12.94
- Average True Range (ATR)
- IGMS 0.07
- NA 1.91
- MACD
- IGMS -0.01
- NA 0.44
- Stochastic Oscillator
- IGMS 4.17
- NA 88.48
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.